Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement
- PMID: 32461815
- PMCID: PMC7244169
- DOI: 10.19102/icrm.2020.110504
Approaches to Minimizing Periprocedural Complications During Subcutaneous Implantable Cardioverter-defibrillator Placement
Abstract
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is the latest option among devices clinically available for the prevention of sudden cardiac death, with experience from previous trials and postmarketing studies supporting the feasibility and safety of this kind of system. The extracardiac positioning of the S-ICD obviates the need for transvenous leads, which translates into lower incidence rates of lead-related complications and systemic infections. This review will highlight the results of pertinent studies related to the perioperative management of S-ICDs and review potential approaches to minimizing the risk of complications such as hematoma at the pulse generator location, unsuccessful defibrillation due to suboptimal S-ICD lead and generator positioning, and postoperative pain. An extensive literature search using PubMed was conducted to identify relevant articles.
Keywords: Complications; periprocedural; subcutaneous implantable cardioverter-defibrillator.
Copyright: © 2020 Innovations in Cardiac Rhythm Management.
Conflict of interest statement
The authors report no conflicts of interest for the published content.
Figures




Similar articles
-
How to minimize peri-procedural complications during subcutaneous defibrillator implant?Expert Rev Cardiovasc Ther. 2020 Jul;18(7):427-434. doi: 10.1080/14779072.2020.1784006. Epub 2020 Jul 2. Expert Rev Cardiovasc Ther. 2020. PMID: 32543951 Review.
-
[Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].Herz. 1994 Oct;19(5):259-77. Herz. 1994. PMID: 8001899 Review. German.
-
Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.Ann N Y Acad Sci. 2014 Nov;1329:1-17. doi: 10.1111/nyas.12550. Epub 2014 Oct 10. Ann N Y Acad Sci. 2014. PMID: 25308791 Review.
-
Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.J Am Coll Cardiol. 2016 Nov 8;68(19):2047-2055. doi: 10.1016/j.jacc.2016.08.044. J Am Coll Cardiol. 2016. PMID: 27810043 Clinical Trial.
-
Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.J Clin Anesth. 2016 Jun;31:53-9. doi: 10.1016/j.jclinane.2015.11.009. Epub 2016 Mar 22. J Clin Anesth. 2016. PMID: 27185678 Clinical Trial.
References
-
- Pfenniger A, Knight BP. Evolution of extravascular implantable defibrillator technologies. Prog Cardiovasc Dis. 2019;62(3):249–255. [CrossRef] [PubMed] - DOI - PubMed
-
- Santini M, Cappato R, Andresen D, et al. Current state of knowledge and experts’ perspective on the subcutaneous implantable cardioverter-defibrillator. J Interv Card Electrophysiol. 2009;25(1):83–88. [CrossRef] [PubMed] - DOI - PubMed
-
- Burke MC, Gold MR, Knight BP, et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol. 2015;65(16):1605–1615. [CrossRef] [PubMed] - DOI - PubMed
LinkOut - more resources
Full Text Sources